Seema Thakore Meloni

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation.

Ogbenna AA, Meloni S, Inzaule S, Hamers RL, Sigaloff K, Osibogun A, Adeyemo TA, Okonkwo P, Samuels JO, Kanki PJ, Rinke de Wit TF, Akanmu AS.

PLoS One. 2020. 15(8):e0238027. PMID: 32841264

Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.

Meloni ST, Agaba P, Chang CA, Yiltok E, Oguche S, Ejeliogu E, Agbaji O, Okonkwo P, Kanki PJ.

PLoS One. 2020. 15(7):e0236801. PMID: 32735566

Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study.

Onwuamah CK, Okpokwu J, Audu R, Imade G, Meloni ST, Okwuraiwe A, Chebu P, Musa AZ, Chaplin B, Dalhatu I, Agbaji O, Samuels J, Ezechi O, Ahmed M, Odaibo G, Olaleye DO, Okonkwo P, Salako BL, Raizes E, Yang C, Kanki PJ, Idigbe EO.

BMC Microbiol. 2020 01 20. 20(1):17. PMID: 31959116

Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria.

Balogun M, Meloni ST, Igwilo UU, Roberts A, Okafor I, Sekoni A, Ogunsola F, Kanki PJ, Akanmu S.

PLoS One. 2019. 14(7):e0219903. PMID: 31344057

The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trial.

Meloni ST, Agbaji O, Chang CA, Agaba P, Imade G, Oguche S, Mukhtar A, Mitruka K, Cox MH, Zee A, Kanki P.

BMC Infect Dis. 2019 May 02. 19(1):368. PMID: 31046695

Predictors of tuberculosis knowledge, attitudes and practices in urban slums in Nigeria: a cross-sectional study.

Balogun MR, Sekoni AO, Meloni ST, Odukoya OO, Onajole AT, Longe-Peters OA, Ogunsola FT, Kanki PJ.

Pan Afr Med J. 2019. 32:60. PMID: 31223352

Retention in Differentiated Care: Multiple Measures Analysis for a Decentralized HIV Care and Treatment Program in North Central Nigeria.

Agaba PA, Genberg BL, Sagay AS, Agbaji OO, Meloni ST, Dadem NY, Kolawole GO, Okonkwo P, Kanki PJ, Ware NC.

J AIDS Clin Res. 2018. 9(2). PMID: 29682399

Quantifying an Adherence Path-Specific Effect of Antiretroviral Therapy in the Nigeria PEPFAR Program.

Miles CH, Shpitser I, Kanki P, Meloni S, Tchetgen EJT.

J Am Stat Assoc. 2017. 112(520):1443-1452. PMID: 32042214

Distinct Pattern of Thymidine Analogue Mutations with K65R in Patients Failing Tenofovir-Based Antiretroviral Therapy.

Chaplin B, Imade G, Onwuamah C, Odaibo G, Audu R, Okpokwu J, Olaleye D, Meloni S, Rawizza H, Muazu M, Musa AZ, Samuel J, Agbaji O, Ezechi O, Idigbe E, Kanki PJ.

AIDS Res Hum Retroviruses. 2018 02. 34(2):228-233. PMID: 29084434

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options.

Meloni ST, Onwuamah CK, Agbaji O, Chaplin B, Olaleye DO, Audu R, Samuels J, Ezechi O, Imade G, Musa AZ, Odaibo G, Okpokwu J, Rawizza H, Mu'azu MA, Dalhatu I, Ahmed M, Okonkwo P, Raizes E, Ujah IAO, Yang C, Idigbe EO, Kanki PJ.

Open Forum Infect Dis. 2017. 4(4):ofx233. PMID: 29255731